COVID-19

Long COVID: U.S. analysis shows significant financial burden

Submitted by mike kraft on Fri, 2025-01-24 10:53

Analysis shows significant financial burden of long COVID in US Approximately 93% to 95% of these costs come from productivity losses. CIDRAP

...

Using current estimates of US long-COVID burden (assuming the probability of long COVID is 6% and symptoms last 1 year), cases cost an average of $2.01 billion annually. The economic burden of long COVID already surpasses that of carpal tunnel, Lyme disease, and psoriasis, the authors said, and is likely to continue to grow.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Long COVID: U.S. analysis shows significant financial burden
Log in or register to post comments

Proposed Trump Order Seeks to Stop Gain-of-Function Virus Research Linked to Covid-19 by Republicans

Submitted by mike kraft on Thu, 2025-01-23 13:21

Trump Order Seeks to Stop Virus Research Linked to Covid-19 by Republicans An executive order is in the works that would halt U.S. funding for research that makes viruses that are more virulent or contagious. Liz Essley Whyte, Nidhi Subbaraman The Wall Street Journal

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Proposed Trump Order Seeks to Stop Gain-of-Function Virus Research Linked to Covid-19 by Republicans
Log in or register to post comments

Azvudine is better than paxlovid in reducing COVID-19 deaths --Chinese study

Submitted by mike kraft on Thu, 2025-01-23 13:10

Azvudine beats paxlovid in reducing COVID-19 deaths In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with added antitumor effects observed. Vijay Kumar Malesu News-Medical

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Azvudine is better than paxlovid in reducing COVID-19 deaths --Chinese study
Log in or register to post comments

Higher risk of long COVID in women, differences among minority kids cited in new studies

Submitted by mike kraft on Thu, 2025-01-23 10:55

Studies note higher risk of long COVID in women, differences among minority kids Compared to the women, the men in the study were older, less likely to be overweight or have asthma, and less likely to report mental health conditions. Men, however, were more likely to report hospitalization during acute infection (10% compared to 7%). CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Higher risk of long COVID in women, differences among minority kids cited in new studies
Log in or register to post comments

Long-Covid Patients want Federal Research programs to work harder to find new treatments

Submitted by mike kraft on Wed, 2025-01-22 10:27

Long-Covid Patients Are Frustrated That Federal Research Hasn't Found New Treatments - KFF Health News The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs. khnkytjaw KFF Health News

...

Despite long covid’s vast reach, the federal government’s investment in researching the disease — to the tune of $1.15 billion as of December — has so far failed to bring any new treatments to market.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem